Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Cipla
Federal Trade Commission
Mallinckrodt
Baxter
Citi

Generated: July 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,987,441

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,987,441 protect, and when does it expire?

Patent 8,987,441 protects XOFLUZA and is included in one NDA.

This patent has twenty-six patent family members in twenty countries.

Summary for Patent: 8,987,441
Title:Substituted polycyclic carbamoyl pyridone derivative prodrug
Abstract: The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3-hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity.
Inventor(s): Takahashi; Chika (Toyonaka, JP), Mikamiyama; Hidenori (Toyonaka, JP), Akiyama; Toshiyuki (Toyonaka, JP), Tomita; Kenji (Toyonaka, JP), Taoda; Yoshiyuki (Toyonaka, JP), Kawai; Makoto (Toyonaka, JP), Anan; Kosuke (Toyonaka, JP), Miyagawa; Masayoshi (Toyonaka, JP), Suzuki; Naoyuki (Toyonaka, JP)
Assignee: Shionogi & Co., Ltd. (Osaka, JP)
Application Number:13/824,723
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 8,987,441
Patent Claim Types:
see list of patent claims
 

Drugs Protected by US Patent 8,987,441

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Genentech Inc XOFLUZA baloxavir marboxil TABLET;ORAL 210854-001 Oct 24, 2018 RX Yes No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Genentech Inc XOFLUZA baloxavir marboxil TABLET;ORAL 210854-002 Oct 24, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,987,441

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2010-213012Sep 24, 2010
PCT Information
PCT FiledSeptember 21, 2011PCT Application Number:PCT/JP2011/071446
PCT Publication Date:March 29, 2012PCT Publication Number: WO2012/039414

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Daiichi Sankyo
QuintilesIMS
Colorcon
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.